According to Heron Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 144,990,000. At the end of 2023 the company had 144,990,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.14 B | 24.05% |
2022 | 0.11 B | 14.61% |
2021 | 0.10 B | 11.96% |
2020 | 91.08 M | 2.21% |
2019 | 89.11 M | 14.12% |
2018 | 78.08 M | 44.13% |
2017 | 54.17 M | 37.92% |
2016 | 39.28 M | 9.04% |
2015 | 36.02 M | 23.32% |
2014 | 29.21 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
SurModics SRDX | 14,102,000 | -90.27% | ๐บ๐ธ USA |
Pacira Biosciences
PCRX | 46,416,000 | -67.99% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | 17,380,000 | -88.01% | ๐บ๐ธ USA |
Alkermes ALKS | 166,607,000 | 14.91% | ๐ฎ๐ช Ireland |
Nektar Therapeutics
NKTR | 190,406,000 | 31.32% | ๐บ๐ธ USA |